Algae Superfood: The Promise and Challenges of Scaling Up Chlorella Vulgaris

Scientists highlight Chlorella Vulgaris’ superfood potential but warn of scaling and consumer acceptance challenges.

UK’s Largest Dementia Blood Test Study Launches

Groundbreaking UK study will assess blood tests for faster, more accurate dementia diagnosis in real-world settings.

FDA Grants Breakthrough Status to Beckman Coulter’s Alzheimer’s Blood Test

New blood test for Alzheimer’s earns FDA Breakthrough Device status, promising earlier, non-invasive diagnosis.

Global Survey Reveals High Trust in Scientists and Public Support for Policymaking Role

Trust in scientists remains strong worldwide, with 83% advocating for their involvement in policymaking.

Unilever and Pioneer Unveil Gastronomica Incubator at Colworth Science Park

Unilever and Pioneer Unveil Gastronomica Incubator at Colworth Science Park

Breakthrough Blood Test Detects Early-Stage Cancer with High Accuracy

Oxford scientists develop a promising blood test using AI to revolutionise early cancer detection.

Revolutionary Composite Material Offers Hope for Neurodegenerative Treatments

Scientists create a biodegradable composite material that could advance treatments for neurodegenerative diseases.

UK Materials Innovation Strategy Aims to Double Jobs and Drive Sustainable Solutions

New strategy promises 100,000 jobs, net-zero progress, and innovation in healthcare, energy, and advanced technologies.

UCLH and GSL Join Forces for Cutting-Edge Neurological Diagnostics

Partnership to develop advanced AI-driven tests for early diagnoses and improved NHS patient outcomes.

Bio-Rad Invests $105 Million to Boost Gastrointestinal Diagnostics

Funding supports ColoSense launch, an at-home colorectal cancer screening test, and innovations in inflammatory bowel disease.

AI-Driven Blood Test Revolutionises Cancer Treatment

New SCORPIO model predicts cancer immunotherapy response using routine blood tests, aiding global accessibility.

Novo Nordisk Invests DKK 8.5bn in Danish Rare Disease Production Facility

Novo Nordisk’s DKK 8.5bn investment in Odense facility supports rare disease treatments and sustainability.

Rapid Saliva Test Revolutionises Paracetamol Overdose Detection

A new saliva-based test quickly identifies paracetamol overdose, improving diagnosis and saving critical treatment time.

New Collaboration Enhances Cancer Diagnostics Across France

Sakura Finetek and MEDIPATH partner to standardise workflows, improving efficiency and cancer diagnosis accuracy.

Urine Tests Offer Hope for Early Lung Cancer Detection

Innovative urine test detects early lung cancer, offering affordable and accessible solutions to improve patient outcomes.

£55m Investment Boosts Precision Medicine in Northern Ireland

Northern Ireland’s £55m investment in precision medicine accelerates personalised treatments and strengthens global healthcare innovation.

Durham University Sets New Standards for Global Surveys

Durham University achieves record-breaking survey response rates, revolutionising global scientific consensus collection for policymaking.

Fast-Track Diagnostics: HKBU’s Breakthrough in Respiratory Pathogen Detection

WHO recommends HKBU’s rapid diagnostic system, capable of detecting 42 pathogens in under 90 minutes.

UK Bolsters Pandemic Defences with H5 Influenza Vaccine

UK buys 5 million H5 influenza vaccine doses, boosting preparedness for potential future pandemics.

Tiny Pasta, Big Potential: UCL’s Nanopasta Breakthrough

UCL scientists craft pasta thinner than light waves, with promising applications beyond the kitchen.